2005Unpublished venueRequires access

Clinical observation on TUOXI+CF+5-FU in the treatment of 25 cases of advanced colorectal cancer.

Ang Yu-li

Open publisher page 0 citations

Abstract

Objective To observe the clinical efficacy and toxicicy of TUOXI+CF+5-FU in the treatment of advanced colorectal cancer.Methods 25 pationts with advanced colorectal cancer were treated with TUOXI 6mg/m 2,i.v.in a 3-hour infusion,d1-5;CF 100mg/m 2,i.v.in a 2-hour infusion,d1-5;5-FU 500mg/m 2,i.v.in a 5-hour infusion,d1-5.The treatment repeated every 3 weeks.All patients received 2 cycles.Results Of 25 evaluable patients, CR+PR was52% ,SD was32%and PD was16%.The main toxic effects were decrease in leukocytes,nause and vomiting,but they were tolerable. Conclusion The regimen of TUOXI+CF+5-FU is effective and tolerable in the treatment of advanced colorectal cancer.

About this research paper

What this paper is about

Objective To observe the clinical efficacy and toxicicy of TUOXI+CF+5-FU in the treatment of advanced colorectal cancer.Methods 25 pationts with advanced colorectal cancer were treated with TUOXI 6mg/m 2,i.v.in a 3-hour infusion,d1-5;CF 100mg/m 2,i.v.in a 2-hour infusion,d1-5;5-FU 500mg/m 2,i.v.in a 5-hour infusion,d1-5.The treatment repeated every 3 weeks.All patients received 2 cycles.Results Of 25 evaluable patients, CR+PR was52% ,SD was32%and PD was16%.The main toxic effects were decrease in leukocytes,nause and vomiting,but they were tolerable. Conclusion The regimen of TUOXI+CF+5-FU is effective and tolerable in the treatment of advanced colorectal cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacy and toxicicy of TUOXI+CF+5-FU in the treatment of advanced colorectal cancer.Methods 25 pationts with advanced colorectal cancer were treated with TUOXI 6mg/m 2,i.v.in a 3-hour infusion,d1-5;CF 100mg/m 2,i.v.in a 2-hour infusion,d1-5;5-FU 500mg/m 2,i.v.in a 5-hour infusion,d1-5.The treatment repeated every 3 weeks.All patients received 2 cycles.Results Of 25 evaluable patients, CR+PR was52% ,SD was32%and PD was16%.The main toxic effects were decrease in leukocytes,nause and vomiting,but they were tolerable. Conclusion The regimen of TUOXI+CF+5-FU is effective and tolerable in the treatment of advanced colorectal cancer.

Key concepts: Medicine, Colorectal cancer, Vomiting, Internal medicine, Gastroenterology, Regimen, Cancer, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on TUOXI+CF+5-FU in the treatment of 25 cases of advanced colorectal cancer. — Research Paper | ScholarLens